Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
Employment agrmnt
|
|
Oncotelic Therapeutics, Inc. (MATN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 425,000 shares
@ $0.021, valued at
$8.9k
Bought 75,000 shares
@ $0.026, valued at
$2k
|
|
| 06/16/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 400,000 shares
@ $0.0326, valued at
$13k
|
|
| 05/31/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 126,888 shares
@ $0.0341, valued at
$4.3k
|
|
| 05/02/2023 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 100,000 shares
@ $0.045, valued at
$4.5k
|
|
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $0.068, valued at
$1.4k
|
|
| 08/29/2022 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Bought 80,000 shares
@ $0.082, valued at
$6.6k
|
|
| 09/08/2021 |
4
| Trieu Vuong (CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 225,000 options
@ $0.1393, valued at
$31.3k
|
|
| 09/08/2021 |
4
| MAIDA ANTHONY E III (Chief Clin. Ops. Officer) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 600,000 options
@ $0.1393, valued at
$83.6k
|
|
| 09/08/2021 |
4
| KING STEVEN W (Director) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 500,000 options
@ $0.1393, valued at
$69.7k
|
|
| 09/08/2021 |
4
| Saund Saran (Chief Business Officer) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 675,000 options
@ $0.1393, valued at
$94k
|
|
| 07/16/2021 |
4
| MAIDA ANTHONY E III (CHIEF CLINICAL OFFICER) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 938,646 shares
@ $0
Converted 938 convertible preferred
@ $0
Granted 400,000 options
@ $0.1626, valued at
$65k
|
|
| 07/16/2021 |
4
| Trieu Vuong (CHAIRMAN AND CEO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 74,455,719 shares
@ $0
Granted 259,302 shares
@ $0
Converted 13,849,161 shares
@ $0
Converted 5,672,025 shares
@ $0
Converted 74,456 convertible preferred
@ $0
Converted 13,849 convertible preferred
@ $0
Converted 5,672 convertible preferred
@ $0
Granted 513,953 options
@ $0.1626, valued at
$83.6k
|
|
| 07/16/2021 |
4
| KING STEVEN W (Director) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 3,291,720 shares
@ $0
Converted 3,292 convertible preferred
@ $0
Granted 357,412 options
@ $0.1626, valued at
$58.1k
|
|
| 07/16/2021 |
4
| Shah Amit B. (CFO) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 298,837 shares
@ $0
Granted 698,256 options
@ $0.1626, valued at
$113.5k
|
|
| 07/16/2021 |
4
| Diamond David (Director) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Granted 451,467 options
@ $0.1626, valued at
$73.4k
|
|
| 07/16/2021 |
4
| Saund Saran (CHIEF BUSINESS OFFICER) has filed a Form 4 on Oncotelic Therapeutics, Inc.|
Txns:
| Converted 16,354,961 shares
@ $0
Granted 102,519 shares
@ $0
Converted 16,355 convertible preferred
@ $0
Granted 216,279 options
@ $0.1626, valued at
$35.2k
|
|
| 11/24/2020 |
4
| Shah Amit B. (CFO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Bought 31,692 shares
@ $0.195, valued at
$6.2k
Bought 20,088 shares
@ $0.19, valued at
$3.8k
Bought 8,220 shares
@ $0.19, valued at
$1.6k
|
|
| 11/23/2020 |
4
| Park Chulho (CHIEF TECHNOLOGY OFFICER) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Bought 22,173 shares
@ $0.1848, valued at
$4.1k
|
|
| 11/23/2020 |
4
| Trieu Vuong (CEO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Bought 50,500 shares
@ $0.19, valued at
$9.6k
|
|
| 03/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2018 |
4
| Schwieterman William D (President and CEO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 500,000 options to buy
@ $0.22, valued at
$110k
|
|
| 06/22/2018 |
4
| SANDAGE BOBBY W. JR., PHD. (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 258,171 options to buy
@ $0.22, valued at
$56.8k
|
|
| 06/22/2018 |
4
| Reynolds Donald Rogers (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 258,171 options to buy
@ $0.22, valued at
$56.8k
|
|
| 06/22/2018 |
4
| Pedder Simon (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 258,171 options to buy
@ $0.22, valued at
$56.8k
|
|
| 06/22/2018 |
4
| LOAR MATTHEW M (CFO) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 250,000 options to buy
@ $0.22, valued at
$55k
Granted 500,000 options to buy
@ $0.22, valued at
$110k
|
|
| 06/22/2018 |
4
| CHAPLIN DAVID (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 258,171 options to buy
@ $0.22, valued at
$56.8k
|
|
| 04/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
4
| Pedder Simon (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 121,483 options to buy
@ $0.51, valued at
$62k
|
|
| 06/12/2017 |
4
| SANDAGE BOBBY W. JR., PHD. (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 121,483 options to buy
@ $0.51, valued at
$62k
|
|
| 06/12/2017 |
4
| Reynolds Donald Rogers (Director) has filed a Form 4 on MATEON THERAPEUTICS INC|
Txns:
| Granted 121,483 options to buy
@ $0.51, valued at
$62k
|
|
|
|
|